Dissociating the cognitive effects of levodopa versus dopamine agonists in a neurocomputational model of learning in Parkinson's disease

Ahmed A. Moustafa, Mohammad M. Herzallah, Mark A. Gluck

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Background/Aims: Levodopa and dopamine agonists have different effects on the motor, cognitive, and psychiatric aspects of Parkinson's disease (PD). Methods: Using a computational model of basal ganglia (BG) and prefrontal cortex (PFC) dopamine, we provide a theoretical synthesis of the dissociable effects of these dopaminergic medications on brain and cognition. Our model incorporates the findings that levodopa is converted by dopamine cells into dopamine, and thus activates prefrontal and striatal D1 and D2 dopamine receptors, whereas antiparkinsonian dopamine agonists directly stimulate D 2 receptors in the BG and PFC (although some have weak affinity to D1 receptors). Results: In agreement with prior neuropsychological studies, our model explains how levodopa enhances, but dopamine agonists impair or have no effect on, stimulus-response learning and working memory. Conclusion: Our model explains how levodopa and dopamine agonists have differential effects on motor and cognitive processes in PD.

Original languageEnglish (US)
Pages (from-to)102-111
Number of pages10
JournalNeurodegenerative Diseases
Volume11
Issue number2
DOIs
StatePublished - Nov 1 2012

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Keywords

  • Basal ganglia
  • Dopamine agonists
  • Levodopa
  • Parkinson's disease
  • Prefrontal cortex
  • Reinforcement
  • Stimulus-response learning
  • Working memory

Fingerprint Dive into the research topics of 'Dissociating the cognitive effects of levodopa versus dopamine agonists in a neurocomputational model of learning in Parkinson's disease'. Together they form a unique fingerprint.

  • Cite this